EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of Vitamin D Supplementation on Bone Mass in Infants With 25-Hydroxyvitamin D Concentrations Less Than 50 nmol/L

Nathalie Gharibeh, Maryam Razaghi, Catherine A Vanstone, Olusola F Sotunde, Laura Glenn, Kristina Mullahoo, Zahra Farahnak, Ali Khamessan, Shu Qin Wei, Dayre McNally, Frank Rauch, Glenville Jones und 2 weitere

JAMA Pediatrics · 01.04.2023 · 177 (4) · 353

DOI: 10.1001/jamapediatrics.2022.5837 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Pediatrics, erschienen am 01.04.2023. Verfasst von Nathalie Gharibeh und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Human Nutrition, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada. Hauptthemen laut MEDLINE: Dietary Supplements, Bone Density, Vitamin D Deficiency, Cholecalciferol. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The dose of supplemental vitamin D needed in infants born with serum 25-hydroxyvitamin D (25[OH]D) concentrations less than 50 nmol/L (ie, 20 ng/mL) is unclear.

Objective

To determine whether a higher dose (1000 IU vs 400 IU per day) is required in infants born with 25(OH)D concentrations less than 50 nmol/L for bone mineral accretion across infancy. Design, Setting, and Participants In this prespecified secondary analysis of a double-blinded randomized clinical trial, conducted from March 2016 to March 2019 in a single center in Greater Montreal, Quebec, Canada, a consecutive sample of 139 healthy term singletons were recruited from 866 infants screened for vitamin D status at birth. Data were analyzed from June 2021 to November 2022.

Interventions

Capillary blood was collected 24 to 36 hours after birth to measure serum total 25(OH)D concentrations. Infants with 25(OH)D concentrations less than 50 nmol/L were randomized to receive either 1000 IU or 400 IU per day of oral vitamin D 3 supplementation from age 1 to 12 months. Infants with 25(OH)D concentrations of 50 nmol/L or greater formed a reference group. Main Outcomes and Measures Measures at age 1, 3, 6, and 12 months were preplanned and included whole-body bone mineral content, lumbar spine bone mineral content, and bone mineral density using dual-energy x-ray absorptiometry, and serum 25(OH)D 3 using liquid chromatography tandem mass spectrometry.

Results

Of 139 included infants, 81 (58.3%) were male, and the median (IQR) gestational age at birth was 39.6 (38.9-40.6) weeks. A total of 49 infants were included in the 1000 IU per day group, 49 infants in the 400 IU per day group, and 41 in the reference group. Mean (SD) whole-body bone mineral content was not different between trial groups over time (1000 IU per day, 173.09 [2.36] g; 400 IU per day, 165.94 [66.08] g). Similarly, no differences were observed in lumbar spine bone mineral content or density. Mean (SD) serum 25(OH)D 3 concentrations were significantly higher in the 1000 IU per day group from age 3 to 12 months (3 months, 115.2 [35.3] nmol/L; 6 months, 121.6 [34.4] nmol/L; 12 months, 99.6 [28.8] nmol/L) compared with the 400 IU per day trial group (3 months, 77.4 [23.3] nmol/L; 6 months, 85.1 [18.6] nmol/L; 12 months, 82.3 [14.3] nmol/L). Conclusions and Relevance In this study, a higher dose of vitamin D supplementation in infants born with 25(OH)D concentrations less than 50 nmol/L did not present advantages to bone mass in infancy. This study supports a standard dose of 400 IU per day of vitamin D supplementation for breastfed infants in Montreal. Trial Registration ClinicalTrials.gov Identifier: NCT02563015

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsBone DensityVitamin D DeficiencyCholecalciferolVitamin DHumansMaleFemaleInfant, NewbornInfantDouble-Blind MethodAbsorptiometry, Photon

Substanzen

Vitamin D25-hydroxyvitamin DCholecalciferol

Autor:innen und Institutionen

  • School of Human Nutrition, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada.
  • Department of Biochemistry, Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada.
  • Europharm International Canada Inc, Montreal, Quebec, Canada.
  • Institut National de Santé Publique du Québec, Montreal, Quebec, Canada.
  • Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
  • Shriners Hospital for Children, Montreal, Quebec, Canada.

Förderung

  • CIHR

Zitieren

APA

Gharibeh, N., Razaghi, M., Vanstone, C. A., Sotunde, O. F., Glenn, L., Mullahoo, K., Farahnak, Z., Khamessan, A., Wei, S. Q., McNally, D., Rauch, F., Jones, G., Kaufmann, M., & Weiler, H. A. (2023). Effect of Vitamin D Supplementation on Bone Mass in Infants With 25-Hydroxyvitamin D Concentrations Less Than 50 nmol/L. JAMA Pediatrics, 177(4), 353. https://doi.org/10.1001/jamapediatrics.2022.5837

Vancouver

Gharibeh N, Razaghi M, Vanstone CA, Sotunde OF, Glenn L, Mullahoo K, et al. Effect of Vitamin D Supplementation on Bone Mass in Infants With 25-Hydroxyvitamin D Concentrations Less Than 50 nmol/L. JAMA Pediatrics. 2023;177(4):353. doi:10.1001/jamapediatrics.2022.5837

BibTeX
@article{Gharibeh2023,
  author = {Gharibeh, Nathalie and Razaghi, Maryam and Vanstone, Catherine A and Sotunde, Olusola F and Glenn, Laura and Mullahoo, Kristina and Farahnak, Zahra and Khamessan, Ali and Wei, Shu Qin and McNally, Dayre and Rauch, Frank and Jones, Glenville and Kaufmann, Martin and Weiler, Hope A},
  title = {Effect of Vitamin D Supplementation on Bone Mass in Infants With 25-Hydroxyvitamin D Concentrations Less Than 50 nmol/L},
  journal = {JAMA Pediatrics},
  year = {2023},
  volume = {177},
  number = {4},
  pages = {353},
  doi = {10.1001/jamapediatrics.2022.5837}
}
Kostenlos starten →